Nearly 200 children across Europe have been born using sperm from a Danish donor carrying an undiscovered cancer risk. The case has raised concerns about cross-border sperm donation and inconsistent fertility regulations in Europe.
Donation Scandal Uncovered
A Danish sperm donor identified as “Kjeld,” also known as donor number 7069, unknowingly passed on a genetic mutation linked to an increased cancer risk. The mutation lies in the TP53 gene, which can elevate the chance of certain types of cancer in children who inherit it.
European Sperm Bank, one of the world’s largest sperm banks, distributed Kjeld’s donations to 67 fertility clinics in 14 countries between 2006 and 2022. The genetic error was discovered two years ago, after which the bank stopped using his sperm. According to Denmark’s Patient Safety Authority, at least 197 children have been born from his donations.
Because of that, health authorities and cancer researchers in several countries are now working to trace these children and offer genetic testing.
A Broader Systemic Breakdown
Experts say the case highlights a serious flaw in Europe’s fertility regulation system. Each country applies its own limits on how many families a donor can help, but there is no shared European registry. This allows donors to exceed the family limits by donating across borders.
In Denmark, where Kjeld began donating in 2005, guidelines at the time suggested no more than 25 Danish children per donor. Despite this, official records show Kjeld became the biological parent of 99 children through Danish clinics alone, roughly half of them born in Denmark.
A nationwide limit of 12 families per donor was introduced in 2013, but no such rule applies across Europe. Because different national systems do not share data, sperm from the same donor can be sold repeatedly in multiple countries.
Wider Reach Across Europe
In Belgium, official records show that 38 women became pregnant using sperm from the same Danish donor, resulting in 53 children. That significantly exceeds Belgium’s limit of six families per donor.
The sperm distribution occurred under European Sperm Bank’s operations, which ship donor samples worldwide. Sperm from this donor traveled across the continent for nearly two decades, with some samples still in use long after the genetic mutation was inherited.
Response From the Sperm Bank
European Sperm Bank declined to provide interviews but acknowledged in a written statement that donor limits were exceeded in some countries. They cited weak reporting systems, incomplete data from clinics, and what they called “fertility tourism” as contributing factors.
The company said it was cooperating with authorities in Denmark and Belgium to improve reporting and compliance. It also pointed to the need for increased coordination among fertility clinics, sperm banks, and national health authorities.
Families Seek Clarity and Testing
The Danish authorities recommend that families who received treatment using this donor’s sperm contact their fertility clinic for advice. Donor-conceived individuals who are concerned about potential risks are encouraged to request genetic testing.
The Patient Safety Authority cannot comment on individual cases but can help families identify where their medical records are held if a clinic has closed.
Families abroad are being directed to contact their national health services or clinics for guidance and screening. For many, this process reveals just how complex the cross-border fertility network has become.
Regulatory Challenges in Reproductive Medicine
The incident has renewed debate about how donors are managed in the fertility industry, particularly in countries like Denmark that export large volumes of donor sperm. Some argue that fertility regulation and health monitoring need to be coordinated beyond national borders.
Meanwhile, the discovery of the TP53 mutation underscores the importance of genetic screening and transparent tracking within assisted reproduction.
Even though Denmark has strict rules for donor screening and medical testing, this case reveals that oversight gaps remain. For newcomers trying to understand the country’s health system, information on Danish healthcare regulations may help clarify how such safety processes work in practice.
Sources and References
The Danish Dream: Danish Healthcare Explained for Tourists & Expats
The Danish Dream: Health Insurance in Denmark for Foreigners
DR: Salg af sæd med uopdaget kræftrisiko har ført til mindst 197 donorbørn
